UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046364
Receipt number R000052908
Scientific Title Effects of standing on a tilting board in postural control and gait
Date of disclosure of the study information 2022/01/01
Last modified on 2022/10/05 09:08:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of standing on a tilting board in postural control and gait

Acronym

Effects of standing on a tilting board in postural control and gait

Scientific Title

Effects of standing on a tilting board in postural control and gait

Scientific Title:Acronym

Effects of standing on a tilting board in postural control and gait

Region

Japan


Condition

Condition

Healthy adults, Parkinson's disease

Classification by specialty

Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of standing on a tilting board in postural control and gait

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Center of pressure, Acceleration at L5 level

Key secondary outcomes

MDS-UPDRS, ABC-scale, MoCA


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Standing on a tilting board

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy adults
People with Parkinson's disease

Key exclusion criteria

People with other diseases to impair postural control or gait

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Naoya
Middle name
Last name Hasegawa

Organization

Hokkaido University

Division name

Department of Rehabilitation Science, Faculty of Health Sciences

Zip code

0600812

Address

Kita-Ku

TEL

0117063531

Email

n_hasegawa@hs.hokudai.ac.jp


Public contact

Name of contact person

1st name Naoya
Middle name
Last name Hasegawa

Organization

Hokkaido University

Division name

Department of Rehabilitation Science, Faculty of Health Sciences

Zip code

0600812

Address

Kita-Ku

TEL

0117063531

Homepage URL


Email

n_hasegawa@hs.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

KAKEN

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University

Address

Kita-Ku

Tel

0117063531

Email

n_hasegawa@hs.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

13

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 01 Month 01 Day

Date of IRB

2022 Year 01 Month 06 Day

Anticipated trial start date

2022 Year 01 Month 10 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 12 Month 13 Day

Last modified on

2022 Year 10 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052908